Trial Profile
Phase IV Study on the Effects of Onabotulinumtoxina Intradetrusorial Injections on Bladder Expression of NGF, TRKA. P75 and TRPV1 in Patients with Detrusor Overactivity.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Biomarker; Pharmacodynamics
- 03 Jul 2012 New trial record